<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><meta name="description" content="The NHANES program was initiated in the early 1960s and beginning in 1999 has been conducted continuously, in two-year cycles. The protocols for each cycle were approved by the NCHS Institutional Review Board. Written informed consent was obtained from each participant."><title>NHANES data, 1999-2020 — nhanes_data • cardioStatsUSA</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.1.3/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.1.3/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- bootstrap-toc --><script src="https://cdn.rawgit.com/afeld/bootstrap-toc/v1.0.1/dist/bootstrap-toc.min.js"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="NHANES data, 1999-2020 — nhanes_data"><meta property="og:description" content="The NHANES program was initiated in the early 1960s and beginning in 1999 has been conducted continuously, in two-year cycles. The protocols for each cycle were approved by the NCHS Institutional Review Board. Written informed consent was obtained from each participant."><meta property="og:image" content="https://jhs-hwg.github.io/cardioStatsUSA/logo.png"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-dark navbar-expand-lg bg-primary"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">cardioStatsUSA</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.0.9000</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="nav-item">
  <a class="nav-link" href="../articles/cardioStatsUSA.html">Get started</a>
</li>
<li class="active nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-results">Results</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-results">
    <a class="dropdown-item" href="../articles/bp_control.html">Blood pressure control</a>
    <a class="dropdown-item" href="../articles/hypertension.html">Hypertension</a>
  </div>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
      </ul><form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off"></form>

      <ul class="navbar-nav"></ul></div>

    
  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>NHANES data, 1999-2020</h1>
      
      <div class="d-none name"><code>nhanes_data.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>The NHANES program was initiated in the early 1960s and beginning in 1999 has been conducted continuously, in two-year cycles. The protocols for each cycle were approved by the NCHS Institutional Review Board. Written informed consent was obtained from each participant.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">nhanes_data</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="format">Format<a class="anchor" aria-label="anchor" href="#format"></a></h2>
    <p>An object of class <code>data.table</code> (inherits from <code>data.frame</code>) with 63041 rows and 98 columns.</p>
    </div>
    <div class="section level2">
    <h2 id="source">Source<a class="anchor" aria-label="anchor" href="#source"></a></h2>
    <p><a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx" class="external-link">https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx</a></p>
    </div>
    <div class="section level2">
    <h2 id="details">Details<a class="anchor" aria-label="anchor" href="#details"></a></h2>
    <p>NHANES data include in-home interviews and study examinations conducted at mobile examination centers. The interview included questions about demographics, health behaviors, prior diagnoses, medication use, and medical history. During the interview, the labels of medications that participants reported taking in the preceding 30 days were recorded. During the study examination, height and weight were measured, blood samples were used to measure cholesterol, glycated hemoglobin and serum creatinine, and a spot urine sample was used to measure albumin and creatinine and to conduct a pregnancy test.</p>
    </div>
    <div class="section level2">
    <h2 id="survey-variables">Survey variables<a class="anchor" aria-label="anchor" href="#survey-variables"></a></h2>
    <p>In each NHANES cycle, potential participants were identified using a
multi-stage sampling process. The variables below are based on this
process.</p><div class="section">
<h3 id="svy-id">svy_id<a class="anchor" aria-label="anchor" href="#svy-id"></a></h3>

<ul><li><p>Label: participant identifier</p></li>
<li><p>Description: NHANES participant unique identifier.</p></li>
</ul></div>

<div class="section">
<h3 id="svy-psu">svy_psu<a class="anchor" aria-label="anchor" href="#svy-psu"></a></h3>

<ul><li><p>Label: primary sampling unit</p></li>
<li><p>Description: Population sampling unit. This variable is used to
account for the non-random selection of study participants for
NHANES</p></li>
</ul></div>

<div class="section">
<h3 id="svy-strata">svy_strata<a class="anchor" aria-label="anchor" href="#svy-strata"></a></h3>

<ul><li><p>Label: strata</p></li>
<li><p>Description: Population stratification. This variable is used to
account for the non-random selection of study participants for
NHANES</p></li>
</ul></div>

<div class="section">
<h3 id="svy-weight-mec">svy_weight_mec<a class="anchor" aria-label="anchor" href="#svy-weight-mec"></a></h3>

<ul><li><p>Label: Mobile examination center weights</p></li>
<li><p>Description: Weight applied to produce statistical estimates for the
non-institutionalized US population. This weight is used for
calculating means and proportions.</p></li>
</ul></div>

<div class="section">
<h3 id="svy-subpop-htn">svy_subpop_htn<a class="anchor" aria-label="anchor" href="#svy-subpop-htn"></a></h3>

<ul><li><p>Label: Subpopulation for hypertension</p></li>
<li><p>Description: This indicates that the person has data needed to be
included in the analysis of blood pressure or hypertension data
(i.e., they had at least one systolic and diastolic blood pressure
measurement and they had information on self-reported
antihypertensive medication use).</p></li>
</ul></div>

<div class="section">
<h3 id="svy-year">svy_year<a class="anchor" aria-label="anchor" href="#svy-year"></a></h3>

<ul><li><p>Label: NHANES cycle</p></li>
<li><p>Description: NHANES survey cycle: 1999-2000, 2001-2002, 2003-2004,
2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014, 2015-2016,
2017-2020</p></li>
</ul></div>

    </div>
    <div class="section level2">
    <h2 id="demographics-variables">Demographics variables<a class="anchor" aria-label="anchor" href="#demographics-variables"></a></h2>
    <p>The NHANES in-home interview included questions about participant
demographics, including age, sex, race/ethnicity, and pregnancy status</p><div class="section">
<h3 id="demo-age-cat">demo_age_cat<a class="anchor" aria-label="anchor" href="#demo-age-cat"></a></h3>

<ul><li><p>Label: Age category, years</p></li>
<li><p>Description: Age grouping: 18-44, 45-64, 65-74, &gt;= 75 years</p></li>
</ul></div>

<div class="section">
<h3 id="demo-race">demo_race<a class="anchor" aria-label="anchor" href="#demo-race"></a></h3>

<ul><li><p>Label: Race</p></li>
<li><p>Description: Self-reported race/ethnicity. From 1999-2000 through
2009-2010 this was available as non-Hispanic White, non-Hispanic
Black, Hispanic and other. From 2011-2012 through 2017-2020 this was
available as non-Hispanic White, non-Hispanic Black, non-Hispanic
Asian, Hispanic and other.</p></li>
</ul></div>

<div class="section">
<h3 id="demo-age-years">demo_age_years<a class="anchor" aria-label="anchor" href="#demo-age-years"></a></h3>

<ul><li><p>Label: Age, years</p></li>
<li><p>Description: Participant age in years. Participants &gt; 80 years of
age are given an age of 80 years.</p></li>
</ul></div>

<div class="section">
<h3 id="demo-pregnant">demo_pregnant<a class="anchor" aria-label="anchor" href="#demo-pregnant"></a></h3>

<ul><li><p>Label: Pregnant</p></li>
<li><p>Description: Pregnancy status. This is defined by either self-report
of being pregnant or a positive pregnancy test conducted during the
study visit.</p></li>
</ul></div>

<div class="section">
<h3 id="demo-gender">demo_gender<a class="anchor" aria-label="anchor" href="#demo-gender"></a></h3>

<ul><li><p>Label: Gender</p></li>
<li><p>Description: Self-reported gender</p></li>
</ul></div>

    </div>
    <div class="section level2">
    <h2 id="blood-pressure-variables">Blood pressure variables<a class="anchor" aria-label="anchor" href="#blood-pressure-variables"></a></h2>
    <p>Systolic and diastolic BP (SBP and DBP, respectively) were measured
three times by trained and certified physicians. BP was measured using a
mercury sphygmomanometer from 1999-2000 through 2015-2016 and using an
oscillometric device in 2017-2020. The oscillometric SBP and DBP values
were calibrated to the mercury device. Mean SBP and DBP levels were
computed over all available</p><div class="section">
<h3 id="bp-sys-mean">bp_sys_mean<a class="anchor" aria-label="anchor" href="#bp-sys-mean"></a></h3>

<ul><li><p>Label: Systolic blood pressure, mm Hg</p></li>
<li><p>Description: Mean systolic blood pressure in mm Hg. This is based on
the average of up to 3 readings. Overall, &gt;95% of participants with
at least one systolic blood pressure reading had three readings.
From 1999-2000 through 2015-2016, systolic blood pressure was
measured using a mercury sphygmomanometer. In 2017-2020, systolic
blood pressure was measured using an oscillometric device. The
systolic blood pressure in 2017-2020 was calibrated to the mercury
device by adding 1.5 mm Hg to the mean measured value.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-dia-mean">bp_dia_mean<a class="anchor" aria-label="anchor" href="#bp-dia-mean"></a></h3>

<ul><li><p>Label: Diastolic blood pressure, mm Hg</p></li>
<li><p>Description: Mean diastolic blood pressure in mm Hg. This is based
on the average of up to 3 readings. Overall, &gt;95% of participants
with at least one diastolic blood pressure reading had three
readings. From 1999-2000 through 2015-2016, diastolic blood pressure
was measured using a mercury sphygmomanometer. In 2017-2020,
diastolic blood pressure was measured using an oscillometric device.
The diastolic blood pressure in 2017-2020 was calibrated to the
mercury device by subtracting 1.0 mm Hg to the mean measured value.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-cat-meds-excluded">bp_cat_meds_excluded<a class="anchor" aria-label="anchor" href="#bp-cat-meds-excluded"></a></h3>

<ul><li><p>Label: Blood pressure category</p></li>
<li><p>Description: Systolic/diastolic blood pressure &lt;120/80,
120-129/&lt;80, 130-139/80-89, 140-159/90-99, &gt;= 160/100.
Participants were placed in the category associated with higher
blood pressure (e.g., someone with systolic blood pressure of 150 mm
Hg and diastolic blood pressure of 76 mm Hg was placed in the &gt;=
140/90 mm Hg category)</p></li>
</ul></div>

<div class="section">
<h3 id="bp-cat-meds-included">bp_cat_meds_included<a class="anchor" aria-label="anchor" href="#bp-cat-meds-included"></a></h3>

<ul><li><p>Label: Blood pressure category (including antihypertensive
medication use)</p></li>
<li><p>Description: Systolic/diastolic blood pressure &lt;120/80,
120-129/&lt;80, 130-139/80-89, 140-159/90-99, &gt;= 160/100.
Participants taking antihypertensive medication were placed in a
separate category. Participants were placed in the category
associated with higher blood pressure (e.g., someone with systolic
blood pressure of 150 mm Hg and diastolic blood pressure of 76 mm Hg
was placed in the &gt;= 140/90 mm Hg category)</p></li>
</ul></div>

<div class="section">
<h3 id="bp-control-jnc-">bp_control_jnc7<a class="anchor" aria-label="anchor" href="#bp-control-jnc-"></a></h3>

<ul><li><p>Label: Blood pressure control (JNC7 guideline)</p></li>
<li><p>Description: Systolic and diastolic blood pressure controlled to the
levels recommended in the JNC7 guideline, systolic blood pressure &lt;
140 mm Hg and diastolic blood pressure &lt; 90 mm Hg.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-control-accaha">bp_control_accaha<a class="anchor" aria-label="anchor" href="#bp-control-accaha"></a></h3>

<ul><li><p>Label: Blood pressure control (2017 ACC/AHA BP guideline)</p></li>
<li><p>Description: Systolic and diastolic blood pressure controlled to the
levels recommended in the 2017 ACC/AHA BP guideline, systolic blood
pressure &lt; 130 mm Hg and diastolic blood pressure &lt; 80 mm Hg
except for those &gt;= 65 years of age without diabetes, chronic
kidney disease, history of cardiovascular disease or 10-year
predicted ASCVD risk &gt;= 10%. For this group, blood pressure control
was defined as systolic blood pressure &lt; 130 mm Hg</p></li>
</ul></div>

<div class="section">
<h3 id="bp-uncontrolled-jnc-">bp_uncontrolled_jnc7<a class="anchor" aria-label="anchor" href="#bp-uncontrolled-jnc-"></a></h3>

<ul><li><p>Label: Uncontrolled BP (JNC7 guideline)</p></li>
<li><p>Description: Systolic blood pressure &gt;= 140 mm Hg or diastolic
blood pressure &gt;= 90 mm Hg</p></li>
</ul></div>

<div class="section">
<h3 id="bp-uncontrolled-accaha">bp_uncontrolled_accaha<a class="anchor" aria-label="anchor" href="#bp-uncontrolled-accaha"></a></h3>

<ul><li><p>Label: Uncontrolled BP (2017 ACC/AHA BP guideline)</p></li>
<li><p>Description: Systolic blood pressure &gt;= 130 mm Hg or diastolic
blood pressure &gt;= 80 mm Hg except for individuals without diabetes,
chronic kidney disease, history of cardiovascular disease or 10-year
predicted ASCVD risk &gt;= 10%. For this group, uncontrolled blood
pressure was defined as systolic blood pressure &gt;= 130 mm Hg</p></li>
</ul></div>

    </div>
    <div class="section level2">
    <h2 id="hypertension-variables">Hypertension variables<a class="anchor" aria-label="anchor" href="#hypertension-variables"></a></h2>
    <p>These variables are derived according to the 2017 American College of
Cardiology/American Heart Association (ACC/AHA) BP guideline and the
Seventh Joint National Committee (JNC7) BP guideline.</p><div class="section">
<h3 id="htn-jnc-">htn_jnc7<a class="anchor" aria-label="anchor" href="#htn-jnc-"></a></h3>

<ul><li><p>Label: Hypertension (JNC7 guideline)</p></li>
<li><p>Description: Hypertension defined by the JNC7 guideline, systolic
blood pressure &gt;= 140 mm Hg, diastolic blood pressure &gt;= 90 mm Hg
or self-reported antihypertensive medication use.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-accaha">htn_accaha<a class="anchor" aria-label="anchor" href="#htn-accaha"></a></h3>

<ul><li><p>Label: Hypertension (2017 ACC/AHA BP guideline)</p></li>
<li><p>Description: Hypertension defined by the 2017 ACC/AHA blood pressure
guideline, systolic blood pressure &gt;= 130 mm Hg, diastolic blood
pressure &gt;= 80 mm Hg or self-reported antihypertensive medication
use.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-aware">htn_aware<a class="anchor" aria-label="anchor" href="#htn-aware"></a></h3>

<ul><li><p>Label: Awareness of hypertension</p></li>
<li><p>Description: Self-report of a prior diagnosis of antihypertensive
medication.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-resistant-jnc-">htn_resistant_jnc7<a class="anchor" aria-label="anchor" href="#htn-resistant-jnc-"></a></h3>

<ul><li><p>Label: Resistant hypertension (JNC7 guideline definition)</p></li>
<li><p>Description: Taking 4 or more classes of antihypertensive
medication, systolic blood pressure &gt;= 140 mm Hg or diastolic blood
pressure &gt;= 90 mm Hg with the use of 3 classes of antihypertensive
medication, or systolic blood pressure &gt;= 130 mm Hg or diastolic
blood pressure &gt;= 80 mm Hg with the use of 3 classes of
antihypertensive medication for those with diabetes or chronic
kidney disease.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-resistant-accaha">htn_resistant_accaha<a class="anchor" aria-label="anchor" href="#htn-resistant-accaha"></a></h3>

<ul><li><p>Label: Resistant hypertension (2017 ACC/AHA BP guideline)</p></li>
<li><p>Description: Taking 4 or more classes of antihypertensive
medication, systolic blood pressure &gt;= 140 mm Hg or diastolic blood
pressure &gt;= 90 mm Hg with the use of 3 classes of antihypertensive
medication, or systolic blood pressure &gt;= 130 mm Hg or diastolic
blood pressure &gt;= 80 mm Hg with the use of 3 classes of
antihypertensive medication for those &lt;65 years of age and those
&gt;= 65 years of age with diabetes, chronic kidney disease or high
cardiovascular risk defined by a history of cardiovascular disease
or 10-year predicted risk &gt;= 10% using the pooled cohort risk
equations.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-resistant-accaha-thz">htn_resistant_accaha_thz<a class="anchor" aria-label="anchor" href="#htn-resistant-accaha-thz"></a></h3>

<ul><li><p>Label: Resistant hypertension (JNC7 guideline, requires thiazide
diuretic)</p></li>
<li><p>Description: Taking 4 or more classes of antihypertensive
medication, systolic blood pressure &gt;= 140 mm Hg or diastolic blood
pressure &gt;= 90 mm Hg with the use of 3 classes of antihypertensive
medication, or systolic blood pressure &gt;= 130 mm Hg or diastolic
blood pressure &gt;= 80 mm Hg with the use of 3 classes of
antihypertensive medication for those &lt; 65 years of age and those
&gt;= 65 years of age with diabetes, chronic kidney disease or high
cardiovascular risk defined by a history of cardiovascular disease
or 10-year predicted risk &gt;= 10% using the pooled cohort risk
equations. To meet this definition of resistant hypertension, the
participant had to be taking a thiazide diuretic.</p></li>
</ul></div>

<div class="section">
<h3 id="htn-resistant-jnc-thz">htn_resistant_jnc7_thz<a class="anchor" aria-label="anchor" href="#htn-resistant-jnc-thz"></a></h3>

<ul><li><p>Label: Resistant hypertension (2017 ACC/AHA BP guideline, requires
thiazide diuretic)</p></li>
<li><p>Description: Taking 4 or more classes of antihypertensive
medication, systolic blood pressure &gt;= 140 mm Hg or diastolic blood
pressure &gt;= 90 mm Hg with the use of 3 classes of antihypertensive
medication, or systolic blood pressure &gt;= 130 mm Hg or diastolic
blood pressure &gt;= 80 mm Hg with the use of 3 classes of
antihypertensive medication for those with diabetes or chronic
kidney disease. To meet this definition of resistant hypertension,
the participant had to be taking a thiazide diuretic.</p></li>
</ul></div>

    </div>
    <div class="section level2">
    <h2 id="antihypertensive-medication-variables">Antihypertensive medication variables<a class="anchor" aria-label="anchor" href="#antihypertensive-medication-variables"></a></h2>
    <p>During the interview, the labels of medications that participants
reported taking in the preceding 30 days were recorded.</p><div class="section">
<h3 id="bp-med-use">bp_med_use<a class="anchor" aria-label="anchor" href="#bp-med-use"></a></h3>

<ul><li><p>Label: Self-reported antihypertensive medication use</p></li>
<li><p>Description: Self-reported use of antihypertensive medication</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-recommended-jnc-">bp_med_recommended_jnc7<a class="anchor" aria-label="anchor" href="#bp-med-recommended-jnc-"></a></h3>

<ul><li><p>Label: Antihypertensive medications recommended (JNC7 guideline)</p></li>
<li><p>Description: Systolic blood pressure &gt;= 140 mm Hg or diastolic
blood pressure &gt;= 90 mm Hg; Systolic blood pressure &gt;= 130 mm Hg
or diastolic blood pressure &gt;= 80 mm Hg for those with chronic
kidney disease or diabetes. Those taking antihypertensive
medications were considered to be recommended treatment by this
definition.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-recommended-accaha">bp_med_recommended_accaha<a class="anchor" aria-label="anchor" href="#bp-med-recommended-accaha"></a></h3>

<ul><li><p>Label: Antihypertensive medications recommended (2017 ACC/AHA BP
guideline)</p></li>
<li><p>Description: Systolic blood pressure &gt;= 140 mm Hg or diastolic
blood pressure &gt;= 90 mm Hg; Systolic blood pressure &gt;= 130 mm Hg
or diastolic blood pressure &gt;= 80 mm Hg for those with chronic
kidney disease, diabetes, 10-year predicted atherosclerotic
cardiovascular disease risk by the pooled cohort risk equations or
age &gt;= 65 years. Those taking antihypertensive medications were
considered to be recommended treatment by this definition.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-n-class">bp_med_n_class<a class="anchor" aria-label="anchor" href="#bp-med-n-class"></a></h3>

<ul><li><p>Label: Number of antihypertensive medication classes</p></li>
<li><p>Description: Number of antihypertensive medication classes being
taken based on the pill bottle review</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-ace">bp_med_ace<a class="anchor" aria-label="anchor" href="#bp-med-ace"></a></h3>

<ul><li><p>Label: ACE inhibitors</p></li>
<li><p>Description: Taking an angiotensin converting enzyme inhibitor,
defined using the pill bottle review. Drugs in this class included
bnazepril, captopril, enalapril, fosinopril, lisonopril, moexipril,
perindopril, quinapril, ramipril, trandolapril</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-aldo">bp_med_aldo<a class="anchor" aria-label="anchor" href="#bp-med-aldo"></a></h3>

<ul><li><p>Label: Aldosterone antagonists</p></li>
<li><p>Description: Taking an aldosterone antagonist, defined using the
pill bottle review. Drugs in this class included eplerenone,
spironolactone.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-alpha">bp_med_alpha<a class="anchor" aria-label="anchor" href="#bp-med-alpha"></a></h3>

<ul><li><p>Label: Alpha-1 blockers</p></li>
<li><p>Description: Taking an alpha blocker, defined using the pill bottle
review. Drugs in this class included doxazosin, prazosin, terazosin.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-angioten">bp_med_angioten<a class="anchor" aria-label="anchor" href="#bp-med-angioten"></a></h3>

<ul><li><p>Label: Angiotensin receptor blockers</p></li>
<li><p>Description: Taking an angiotensin receptor blocker, defined using
the pill bottle review. Drugs in this class included candesartan,
eprosartan, irbesartan, losartan, olmesartan, telmisartan,
valsartan, azilsartan.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-beta">bp_med_beta<a class="anchor" aria-label="anchor" href="#bp-med-beta"></a></h3>

<ul><li><p>Label: Beta blockers</p></li>
<li><p>Description: Taking a beta blocker. Drugs in this class included
acebutolol, atenolol, betaxolol, bisoprolol, carvedilol, labetalol,
metoprolol, nadolol, nebivolol, pindolol, propranolol.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-central">bp_med_central<a class="anchor" aria-label="anchor" href="#bp-med-central"></a></h3>

<ul><li><p>Label: Central alpha1 agonist and other centrally acting agents</p></li>
<li><p>Description: Taking a centrally acting agents, defined using the
pill bottle review. Drugs in this class included clonidine,
guanabenz, guanfaacine, methyldopa, reserpine.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-ccb">bp_med_ccb<a class="anchor" aria-label="anchor" href="#bp-med-ccb"></a></h3>

<ul><li><p>Label: Calcium channel blockers</p></li>
<li><p>Description: Taking a calcium channel blocker, defined using the
pill bottle review. Drugs in this class included amlodipine,
diltiazem, felodipine, isradipine, nicardipine, nifedipine,
nisoldipine, verapamil.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-diur-ksparing">bp_med_diur_Ksparing<a class="anchor" aria-label="anchor" href="#bp-med-diur-ksparing"></a></h3>

<ul><li><p>Label: Potassium sparing diuretics</p></li>
<li><p>Description: Taking a potassium-sparing diuretic, defined using the
pill bottle review. Drugs in this class included amiloride,
triamterene.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-diur-loop">bp_med_diur_loop<a class="anchor" aria-label="anchor" href="#bp-med-diur-loop"></a></h3>

<ul><li><p>Label: Loop diuretics</p></li>
<li><p>Description: Taking a loop diuretic, defined using the pill bottle
review. Drugs in this class included bumetanide, furosemide,
torsemide, ethacrynic acid.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-diur-thz">bp_med_diur_thz<a class="anchor" aria-label="anchor" href="#bp-med-diur-thz"></a></h3>

<ul><li><p>Label: Thiazide or thiazide-type diuretics</p></li>
<li><p>Description: Taking a thiazide diuretic, defined using the pill
bottle review. Drugs in this class included bendroflumethiazide,
chlorthalidone, chlorothiazide, hydrochlorothiazide, indapamide,
metolazone, polythiazide.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-renin-inhibitors">bp_med_renin_inhibitors<a class="anchor" aria-label="anchor" href="#bp-med-renin-inhibitors"></a></h3>

<ul><li><p>Label: Direct renin inhibitors</p></li>
<li><p>Description: Taking a renin inhibitor, defined using the pill bottle
review. Drugs in this class included aliskiren.</p></li>
</ul></div>

<div class="section">
<h3 id="bp-med-vasod">bp_med_vasod<a class="anchor" aria-label="anchor" href="#bp-med-vasod"></a></h3>

<ul><li><p>Label: Direct vasodilators</p></li>
<li><p>Description: Taking a vasodilator, defined using the pill bottle
review. Drugs in this class included hydralazine, minoxidil.</p></li>
</ul></div>

    </div>
    <div class="section level2">
    <h2 id="comorbidities-variables">Comorbidities variables<a class="anchor" aria-label="anchor" href="#comorbidities-variables"></a></h2>
    <p>These variables describe comorbid conditions.</p><div class="section">
<h3 id="cc-n-highrisk">cc_n_highrisk<a class="anchor" aria-label="anchor" href="#cc-n-highrisk"></a></h3>

<ul><li><p>Label: Number of high risk conditions</p></li>
<li><p>Description: Self-reported history of coronary heart disease,
myocardial infarction, stroke or heart failure or 10-year predicted
risk &gt;= 10% estimated by the pooled cohort risk equations</p></li>
</ul></div>

<div class="section">
<h3 id="cc-smoke">cc_smoke<a class="anchor" aria-label="anchor" href="#cc-smoke"></a></h3>

<ul><li><p>Label: Smoking status</p></li>
<li><p>Description: Self-reported current cigarette smoking</p></li>
</ul></div>

<div class="section">
<h3 id="cc-bmi">cc_bmi<a class="anchor" aria-label="anchor" href="#cc-bmi"></a></h3>

<ul><li><p>Label: Body mass index, kg/m2</p></li>
<li><p>Description: Body mass index in kg/m2, estimated using the height
and weight measured during the study examination.</p></li>
</ul></div>

<div class="section">
<h3 id="cc-diabetes">cc_diabetes<a class="anchor" aria-label="anchor" href="#cc-diabetes"></a></h3>

<ul><li><p>Label: Prevalent diabetes</p></li>
<li><p>Description: HbA1c &gt;= 6.5% or self-report of a prior diagnosis of
diabetes with use of insulin or oral glucose-lowering medications.</p></li>
</ul></div>

<div class="section">
<h3 id="cc-ckd">cc_ckd<a class="anchor" aria-label="anchor" href="#cc-ckd"></a></h3>

<ul><li><p>Label: Prevalent chronic kidney disease</p></li>
<li><p>Description: Estimated glomerular filtration rate &lt; 60 ml/min/1.73
m2 or albumin-to-creatinine &gt; 30 mg/g. Estimated glomerular
filtration rate was calculated using the 2021 serum creatinine-based
equation.</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-mi">cc_cvd_mi<a class="anchor" aria-label="anchor" href="#cc-cvd-mi"></a></h3>

<ul><li><p>Label: History of myocardial infarction</p></li>
<li><p>Description: Self-reported history of myocardial infarction</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-chd">cc_cvd_chd<a class="anchor" aria-label="anchor" href="#cc-cvd-chd"></a></h3>

<ul><li><p>Label: History of coronary heart disease</p></li>
<li><p>Description: Self-reported history of myocardial infarction or
coronary heart disease</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-stroke">cc_cvd_stroke<a class="anchor" aria-label="anchor" href="#cc-cvd-stroke"></a></h3>

<ul><li><p>Label: History of stroke</p></li>
<li><p>Description: Self-reported history of stroke</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-ascvd">cc_cvd_ascvd<a class="anchor" aria-label="anchor" href="#cc-cvd-ascvd"></a></h3>

<ul><li><p>Label: History of ASCVD</p></li>
<li><p>Description: Self-reported history of coronary heart disease,
myocardial infarction or stroke</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-hf">cc_cvd_hf<a class="anchor" aria-label="anchor" href="#cc-cvd-hf"></a></h3>

<ul><li><p>Label: History of heart failure</p></li>
<li><p>Description: Self-reported history of heart failure</p></li>
</ul></div>

<div class="section">
<h3 id="cc-cvd-any">cc_cvd_any<a class="anchor" aria-label="anchor" href="#cc-cvd-any"></a></h3>

<ul><li><p>Label: History of CVD</p></li>
<li><p>Description: Self-reported history of coronary heart disease,
myocardial infarction, stroke or heart failure</p></li>
</ul></div>

    </div>

  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p></p><p>Developed by Byron Jaeger, Ligong Chen, Paul Muntner.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.6.</p>
</div>

    </footer></div>

  

  

  </body></html>

